Skip to main content

GOLDMAN SACHS GROUP INC

Position in IMVT — Immunovant, Inc.

CIK 886982 NEW YORK, NY

Position in IMVT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$67,473,080
+$23,131,023 QoQ
Shares Held
1,751,183
-1.9% QoQ
Ownership
0.848%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#19
of 226 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 98% Shared 0% None 1%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. IMVT ranks #51 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IMVT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $67,473,080 1,751,183
2026-03-31 $44,342,057 1,785,107
2025-12-31 $32,944,523 1,296,008
2025-09-30 $23,898,528 1,482,539
2025-06-30 $19,128,256 1,195,516
2025-03-31 $17,221,592 1,007,700
2024-12-31 $16,802,629 678,346
2024-09-30 $14,872,896 521,673
2024-06-30 $10,874,634 411,918
2024-03-31 $11,281,907 349,177
2023-12-31 $19,301,058 458,131
2023-09-30 $19,595,791 510,440
2023-06-30 $6,169,916 325,246
2023-03-31 $6,837,706 440,858
2022-12-31 $6,589,652 371,248
2022-09-30 $396,564 71,069
2022-06-30 $955,312 244,952
2022-03-31 $1,959,873 355,694
2021-12-31 $2,503,592 293,849
2021-09-30 $3,988,475 458,973
2021-06-30 $2,174,607 205,734
2021-03-31 $16,783,950 1,046,381
2020-12-31 $36,340,212 786,755
2020-09-30 $4,338,962 123,301
2020-06-30 $3,665,575 150,537
2020-03-31 $1,149,350 73,842